Skip to main content
رجوع
Watch Compare

Zivo Bioscience, Inc.

جودة البيانات: 100%
مُدرج أيضًا باسم ZIVOW OTC
ZIVO
OTC Manufacturing Chemicals
KWD 3.25
▼ KWD 0.35 (-9.72%)
القيمة السوقية: 12.64 M
السعر
KWD 3.25
القيمة السوقية
12.64 M
نطاق اليوم
KWD 3.00 — KWD 4.00
نطاق 52 أسبوعًا
KWD 3.00 — KWD 20.00
حجم التداول
3,644
فتح KWD 4.00
متوسط 50 يوم / 200 يوم
KWD 9.03
64.00% below
متوسط 50 يوم / 200 يوم
KWD 11.70
72.23% below

Quick Summary

النقاط الرئيسية

Revenue grew 67.44% annually over 5 years — strong growth
Negative free cash flow of -3.08 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 401.17%

النمو

Revenue Growth (5Y)
67.44%
أعلى من متوسط القطاع (1.82%)
Revenue (1Y)468.61%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
N/A
ROICN/A
Net Margin-4059.73%
Op. Margin-4045.65%

الأمان

Debt / Equity
N/A
Current Ratio0.08
Interest CoverageN/A

التقييم

PE (TTM)
-1.49
أقل من متوسط القطاع (-1.48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (1364 نظير)
المقياس السهم وسيط القطاع
P/E -1.5 -1.5
P/B — 1.6
ROE % — -53.4
Net Margin % -4059.7 -41.5
Rev Growth 5Y % 67.4 1.8
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) 468.61% Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 67.44% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 209,025.0 Net Income (TTM) -8.49 M
ROE N/A ROA -1344.00%
Gross Margin 31.68% Operating Margin -4045.65%
Net Margin -4059.73% Free Cash Flow (TTM) -3.08 M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.08
Interest Coverage N/A Asset Turnover 0.33
Working Capital -3.33 M Tangible Book Value -3.29 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1.49 Forward P/E N/A
P/B Ratio N/A P/S Ratio 60.46
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -24.36%
Market Cap 12.64 M Enterprise Value 12.64 M
Per Share
EPS (Diluted TTM) -6.05 Revenue / Share 0.05
FCF / Share -0.79 OCF / Share -0.79
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 36.28%
SBC-Adj. FCF N/A Growth Momentum 401.17

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue 157,220.0 27,650.0 0.0 0.0 20,000.0
Net Income -13.38 M -7.78 M -8.75 M -9.16 M -9.11 M
EPS (Diluted) -4.23 — — — —
Gross Profit 48,952.0 11,610.0 — — —
Operating Income -13.36 M -7.26 M -8.73 M -9.05 M -8.56 M
EBITDA — — — — —
R&D Expenses 3.13 M 1.38 M 2.24 M 2.12 M 3.75 M
SG&A Expenses — — — — —
D&A — — — 0.0 0.0
Interest Expense — 23,793.0 13,319.0 44,677.0 —
Income Tax — — — — —

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 1.64 M 555,715.0 2.12 M 8.99 M 220,179.0
Total Liabilities 2.16 M 2.76 M 2.13 M 2.95 M 11.53 M
Shareholders' Equity -514,897.0 -2.21 M -10,622.0 6.04 M -11.31 M
Total Debt — — — — —
Cash & Equivalents — — 1.80 M 8.90 M 137,862.0
Current Assets 1.64 M 425,377.0 1.90 M 8.96 M 167,815.0
Current Liabilities 2.04 M 2.76 M 2.03 M 2.95 M 11.39 M